Search

Displaying results 5971 - 5980 of 9702 in total
  1. Drug

    Etentamig

    go.drugbank.com/drugs/DB17268
    Investigational

    TNB-383B is a CD3 and B-cell maturation antigen T-cell engaging bispecific antibody.

  2. Drug

    Cirtuvivint

    go.drugbank.com/drugs/DB17269
    Investigational

    Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.

  3. Drug

    Disufenton

    go.drugbank.com/drugs/DB17298
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  4. Drug

    NC-6300

    go.drugbank.com/drugs/DB17341
    Experimental

    NC-6300, also known as K-912, is a novel [epirubicin] drug-conjugated polymeric micelle.

  5. Drug

    Trimethyltetradecylammonium

    go.drugbank.com/drugs/DB17342
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    Ocaratuzumab

    go.drugbank.com/drugs/DB17359
    Investigational

    Ocaratuzumab is a humanized monoclonal antibody directed against CD20. It is being investigated for cancers and autoimmune disorders.

    Synonyms: Immunoglobulin G1, anti-(human B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1, Bp35, leukocyte surface antigen Leu-16, membrane-spanning 4-domains subfamily A member 1))
  7. Drug

    LioCyx-M004

    go.drugbank.com/drugs/DB17368
    Investigational

    LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.

  8. Drug

    TBX-3400

    go.drugbank.com/drugs/DB17370
    Investigational

    TBX-3400 is an investigational cell-based immunotherapy consisting of autologous peripheral blood mononuclear cells (PBMCs) treated ex vivo with TBX-4000, which is a recombinant TAT-MYC fusion protein.

  9. Drug

    Zanolimumab

    go.drugbank.com/drugs/DB17376
    Investigational

    Zanolimumab is a fully human monoclonal antibody directed against CD4.

  10. Drug

    MVR-T3011

    go.drugbank.com/drugs/DB17378
    Investigational

    MVR-T3011 is a genetically modified oncolytic Herpes Simplex Virus (HSV-1) with 2 exogenous genes encoding the active heterodimer human interleukin 12 (IL-12) and the Fab fragment of an anti-human PD-1